Accueil   Diary - News   All news Oncofactory


 « To accelerate the personalization of therapies in oncology »




OncoFactory operates a unique technological platform exploiting an innovative patient-derived xenograft (PDX) animal model, the avian embryo. Miniature replicas of tumors from patient samples are created in a series of embryos in only a few days, for a large range of investigations.



Our technology allows modeling the heterogeneity of patient tumors, statistical analysis of treatment efficacies, and a range of molecular analyses for biomarker and therapeutic target discovery.